Complementary asymmetric routes to fused tricyclic (R)-2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinolines and (R)-1,2,3,4,5,5a,6,7-octahydro-[1,4]diazepino[1,2-a]quinolines
Thomas O. Schrader(Arena Pharmaceuticals (United States)), Graeme Semple(Eurofins (United States)), Qi Sun(Shanxi University), Michelle Kasem(Arena Pharmaceuticals (United States)), Albert Ren, Chunrui Wu(Tiangong University)
Cited by 5
Related Papers
A Role for β-Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucose-Dependent Insulin Release
|Endocrinology|2007|294
Red-Emissive Ruthenium-Containing Carbon Dots for Bioimaging and Photodynamic Cancer Therapy
|ACS Applied Nano Materials|2020|161
Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119
|Journal of Medicinal Chemistry|2008|142
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
|Blood|2021|125
Oligo(ethylene glycol)-Functionalized Ratiometric Fluorescent Probe for the Detection of Hydrazine in Vitro and in Vivo
|Analytical Chemistry|2019|117